Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
-min.png)
Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.